Results 271 to 280 of about 1,068,824 (393)

Interactions between glycosaminoglycans and proteins, with particular reference to a new technique for isolating serum glycoproteins [PDF]

, 1967
A. J. Anderson
openalex   +1 more source

The antigenic structure of the HIV gp120 envelope glycoprotein

Nature, 1998
R. Wyatt, P. Kwong, E. Desjardins, R. Sweet, James E. Robinson, W. Hendrickson, J. Sodroski   +6 more
semanticscholar   +1 more source

Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility

Advanced Therapeutics, EarlyView.
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam, Lu Yanjun, Bee Luan Khoo, Tongxu Si, Heng Zou, Mengsu Yang   +5 more
wiley   +1 more source

Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Proangiogenic Mediators in Sickle Cell Disease [PDF]

Turk J Haematol
Kleebayoon A, Wiwanitkit V.
europepmc   +1 more source

The Amino-terminal Peptide of α1-Acid Glycoprotein

, 1966
Tokuji Ikenaka, H. Bammerlin, H. Kaufmann, Karl Schmid   +3 more
openalex   +1 more source

Paper Electrophoretic Studies of Glycoproteins in Rheumatic Fever [PDF]

, 1960
Leonard R Gorczyca, J A Lazaroni, Elisabeth Maier   +2 more
openalex   +1 more source

Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. [PDF]

, 2002
BAUMANN, H, BERGER, FG, Brouckaert, Peter, Hochepied, Tino, Libert, Claude, Steidler, Lothar, Wullaert, Andy   +6 more
core   +2 more sources

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Advanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan, Yaping Chen   +7 more
wiley   +1 more source

The subcellular acquisition of carbohydrates by glycoproteins [PDF]

, 1969
Nicholas J. Cowan, Garth B. Robinson
openalex   +1 more source

Enhanced Doxorubicin Cytotoxicity on Breast Cancer Spheroids by Aptamer Targeted Co‐Delivery with Hyaluronidase

Advanced Therapeutics, EarlyView.
Breast cancer is one of the most prevalent solid tumors in women. Doxorubicin is loaded mesoporous silica nanoparticles, capped with HER2‐specific aptamers, and the particle surface is functionalized with hyaluronidase. This dual‐functionalized nanocarrier system offers a promising solution for the drug resistance by solid tumors.
Murat Kavruk, Dide Su Demirel, Farzaneh Bonyadi, Buket Çakmak Güner, Ali Doğan Dursun, Cekdar Vakifahmetoglu, Bilge Güvenç Tuna, Uğur Şahin, Veli Cengiz Ozalp   +8 more
wiley   +1 more source